Monoclonal antibodies Flashcards

1
Q

How does monoclonal antibodies work in general ?

A

They target specific antigens that are over expressed on the tumour cell surface and create MAC complexes which cause complement mediated cell lysis or the monoclonal anti-bodies trigger immune mediated destruction. All monoclonal antibodies are administered IV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the speciality of human cell derived monoclonal antibodies which ends with ‘ umab’ ?

A

They are less likely to cause HSR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the speciality of chimeric antibodies ends with ‘ Ximab’ ?

A

They have both human and non-human components. They are more likely to be recognized as foreign leading to HSR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is the speciality of humanised monoclonal antibodies ends in ‘Zumab’ ?

A

These are drugs derived from non human species and are less likely to cause HSR as compared to chimeric antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the MOA of Cetuximab ?

A

It inhibits the activation of K-RAS pathway by binding to the tyrosine kinase receptor EGFR resulting in inhibition of cell proliferation, migration , and angiogenesis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the indications for Cetuximab ?

A

They are indicated for the Tx of metastatic colorectal cancer as well as Head and neck cancers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the side effects of chimeric antibody Cetuximab?

A
  • infusion HSR
  • GI and hepatic toxicity.
  • Acniform skin rashes with pruritus.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the MOA and indication of Trastuzumab ( Herceptin) ?

A

It is a HER2 receptor antagonist which act by inhibiting HER2 mediated tumorogenesis by inhibiting the signaling through PI3K AKt mTOR pathway, and MAPK pathway. It is mainly used to treat HER2 positive breast cancer. It is also used to treat gastric, ovarian, and lung cancers caused by HER2 mutation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the main side effect of Trastuzumab ?

A

Inhibition of HER2 receptors on the normal cardiomyocytes leads to cardiotoxic heart failure. Other side effects are GI disturbances, fever, chills, and headaches.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA and indication of Bevacizumab?

A

It inhibits VEGF and prevent angiogenesis of the solid tumours leading to the apoptosis of the tumour cells. It is used to treat colorectal cancer, renal cell carcinoma, breast cancer and non-small cell lung cancer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the side effects of Bevacizumab ?

A
  • Impaired angiogenesis of normal tissue.
  • Impaired wound healing.
  • Epistaxis and hemoptysis.
  • GI and intracerebral haemorrhage.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the MOA and indication of Rituximab ?

A

It binds to the CD20 receptor of the B cell and drives cmplement mediated MAC formation which causes pores on the cell leading to cell lysis. In addition, it also enhance apoptosis signaling and anti-body dependent cell mediated cytotoxicity.
It is indicated for the Tx of non-hodgkins B cell lymphoma, CLL, Ideopathic thormbocytopaenic purpura and RA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the side effects of Rituximab ?

A
  • HSR and immune supression.
  • Activation of latent viral infections.
  • JC virus activation leading to progressive multifocal leukoencephalopathy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MOA and indication of Alemtuzumab ?

A

It acts by binding to CD52 receptors of all lymphocytes and destroy them through complement mediated lysis, apoptosis, and phagocytosis by NK cells. It is indicated to treat CLL and MS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the MOA and indication of Imatinibe ?

A

It inhibits the signaling mediated by the BCR-ABL gene formed by the 9 , 22 chromosomal translocation. It is indicated to treat the Philadelphia chromosome positive CML.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the MOA of dual pan PI3K and mTOR inhibitors ?

A

They target P85 subunit and mTOR simultaneously. improved therapeutic effect due to the more efficient inhibition of the PI3K- Akt- mTOR pathway, but greater toxicities and side effects.

17
Q

What is the target of pan PI3K inhibitors ?

A

The p110 subunit of PI3K.
they have greater anticancer activity.Less toxicity and dual inhibitory effect.

18
Q

What is the target of Isoform-selective PI3K inhibitors?

A

catalytic isoforms of P110 (alpha,beta ,delta). They are less toxic hence can be administered at higher doses.

19
Q

What are the cancers in which PI3K-AKT-mTOR pathway is implicated ?

A

Breast and liver cancer.

20
Q

What is the action and indication of Alpelisib ?

A

It is a P110 alpha isoform specific oral agent. which can be given orally at a maximum dose of 300 mg/day for the treatment of PICK3CA positive breast cancer.

21
Q

What are the drugs used to treat EGFR positive non-small cell lung cancers?

A

Lapatinib, Erlotinib and Gefitinib all inhibit the kinase activity of EGFR by competing for ATP binding.

22
Q

What is the MOA of BRAF inhibitor Vemurafenib?

A

It is a oral selective inhibitor of BRAF kinase used to treat V600 E positive cancers such as melanoma. Inhibition of BRAF kinase stops ERK signalling cascade. However, resistance occurs in 2-18 months. If there are downstream target mutations combining it with MEK inhibitor Trametinib can help.